Si-Bone (SIBN) EBITDA Margin (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Si-Bone | 611.92 Mn | 471.80 Mn | 41.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -600.00 |
| Dec 31, 2025 | 631.00 |
| Sep 30, 2025 | 280.00 |
| Jun 30, 2025 | 172.00 |
| Mar 31, 2025 | -381.00 |
| Dec 31, 2024 | 556.00 |
| Sep 30, 2024 | 704.00 |
| Jun 30, 2024 | 652.00 |
| Mar 31, 2024 | -66.00 |
| Dec 31, 2023 | 98.00 |
| Sep 30, 2023 | 436.00 |
| Jun 30, 2023 | 15.00 |
| Mar 31, 2023 | 93.00 |
| Dec 31, 2022 | 1,835.00 |
| Sep 30, 2022 | 1,955.00 |
| Jun 30, 2022 | 605.00 |
| Mar 31, 2022 | -2,102.00 |
| Dec 31, 2021 | 1,370.00 |
| Sep 30, 2021 | -851.00 |
| Jun 30, 2021 | -251.00 |
| Mar 31, 2021 | -2,022.00 |
| Dec 31, 2020 | 726.00 |
| Sep 30, 2020 | 4,201.00 |
| Jun 30, 2020 | -1,485.00 |
| Mar 31, 2020 | -2,856.00 |
| Dec 31, 2019 | 2,414.00 |
| Sep 30, 2019 | -1,752.00 |
| Jun 30, 2019 | 970.00 |
| Mar 31, 2019 | -2,834.00 |
| Dec 31, 2018 | 189.00 |
| Sep 30, 2018 | -1,320.00 |
| Jun 30, 2018 | 1,057.00 |
| Mar 31, 2018 | 248.00 |
| Dec 31, 2017 | 1,316.00 |